跳至主要内容
临床试验/CTRI/2023/11/059515
CTRI/2023/11/059515招募中不适用

A Single blind Clinical study to evaluate the eye stinging potential of Piramal’s Multiple Baby care products.

Piramal Pharma Limited1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年11月12日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
•Change in lacrimation

研究概览

简要总结

In Visit 1/Day 0

Step 1: Firstly, the subject enrolls into the study as per inclusion and exclusion criteria

Step 2: Assessment of the subject as per discussed above (refer to study design)

 In Visit 2/ Day 1

        To check the irritation potential of the Multiple Baby Care Products.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Healthy males or females, 18 to 60 years with no medical conditions of the eyes as determined by the subjects medical history and confirmed by an ophthalmologist
  • Subjects not under any doctor care for ocular or peri orbital diseases
  • The subject will refrain from using contact lenses, any topical facial products, any eye drops, false eyelashes, make up, over the counter products, or cosmetics on their eyes, eyelids, eyelashes, or the periorbital areas of the face during the study.

排除标准

  • 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 4.Have participated in any interventional clinical trial in the previous 30 days.
  • 5.Have a known sensitivity to any of the constituents of the test product including sensitivities to cocoamidopropyl betaine, coumarin, Aloe barbadensis etc.
  • 6.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 7.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

结局指标

主要结局

•Change in lacrimation

时间窗: [Time frame 0-1 days] | [Time frame 0-1 days] | [Time frame 0-1 days]

•Change in conjunctival inflammation.

时间窗: [Time frame 0-1 days] | [Time frame 0-1 days] | [Time frame 0-1 days]

•Change in cornea and iris inflammation .

时间窗: [Time frame 0-1 days] | [Time frame 0-1 days] | [Time frame 0-1 days]

次要结局

  • Not applicable(Not applicable)

研究者

申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Ishika Gandhi

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验